Human breast cancer cell line MDA-MB-231 expresses endogenous A 2B adenosine receptors mediating a Ca 2+ signal

British Journal of Pharmacology

Volumn 145, Issue 2, 2005, Pages 211-218

  Panjehpour, Mojtaba ^a   Castro, Marián ^a   Klotz, Karl Norbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

A 2B; Adenosine; Adenosine receptor; Breast cancer; Ca 2+ signal; Effector coupling; Human, cancer; Second messenger

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 (3 HYDROXY 3 PHENYL)PROPYN 1 YLADENOSINE 5' N ETHYLURONAMIDE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; 9 ETHYL 8 FURYLADENINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; ANR 152; CALCIUM ION; MEMBRANE PROTEIN; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADENYLATE CYCLASE; BREAST NEOPLASMS; CALCIUM SIGNALING; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A2B;

EID: 19944411507     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706180     Document Type: Article

References (42)

1. 2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies. J. Biol. Chem., 271, 1748-1755.
2. 2B4) cells. Br. J. Pharmacol., 119, 1286-1290.
3. AUCHAMPACH, J.A. & BOLLI, R. (1999). Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges. Am. J. Physiol., 276, H1113-H1116.
4. 2B receptor. Mol. Pharmacol., 52, 846-860.
5. 2B adenosine receptor antagonists. J. Med. Chem., 47, 1434-1447.
6. BERRIDGE, M.J., LIPP, P. & BOOTMAN, M.D. (2000). The versatility and universatility of calcium signalling. Nat. Rev. Mol. Cell Biol., 1, 11-21.
7. BLAY, J., WHITE, T.D. & HOSKIN, D.W. (1997). The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res., 57, 2602-2605.
8. BRUNS, R.F. (1980). Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol., 58, 673-691.
9. CLAPHAM, D.E., MONTELL, C., SCHULTZ, G. & JULIUS, D. (2003). International union of pharmacology. XLIII. Compendium of voltage-gated ion channels: transient receptor potential channels. Pharmacol. Rev., 55, 591-596.
10. DE LEAN, A., HANCOCK, A.A. & LEFKOWITZ, R.J. (1982). Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol., 21, 5-16.
11. 3 adenosine receptors in CHO cells. Biochem. Pharmacol., 64, 69-73.
12. 2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest., 96, 1979-1986.
13. 2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells. Mol. Pharmacol., 45, 1160-1167.
14. 2B receptors: a novel therapeutic target in asthma? Trends Pharmacol. Sci., 19, 148-153.
15. 3 adenosine receptor inhibits colon carcinoma growth inmice via modulation of GSK-3β and NF-κ. Oncogene, 23, 2465-2471.
16. FREDHOLM, B.B., IJZERMAN, A.P., KLOTZ, K.-N. & LINDEN, J. (2001a). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 1-26.
17. FREDHOLM, B.B., IRENIUS, E., KULL, B. & SCHULTE, G. (2001b). Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol., 61, 443-448.
18. 1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and phospholipase C. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 49-56.
19. GANOTE, C.E. & ARMSTRONG, S.C. (2000). Adenosine and preconditioning in the rat heart. Cardiovasc. Res., 45, 134-140.
20. 2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells cross-talk between cyclic AMP and protein kinase C pathways. J. Biol. Chem., 274, 5972-5980.
21. 2B-selective adenosine receptor antagonists. J. Med. Chem., 45, 1500-1510.
22. ILLES, P., KLOTZ, K.-N. & LOHSE, M.J. (2000). Signaling by extracellular nucleotides and nucleosides. Naunyn-Schmiedeberg's Arch. Pharmacol., 362, 295-298.
23. 2B adenosine receptors. Drug Des. Discov., 16, 217-226.
24. 2B adenosine receptors. Drug Dev. Res., 47, 178-188.
25. KITAKAZE, M. & HORI, M. (2000). Adenosine therapy: a new approach to chronic heart failure. Expert Opin. Inv. Drug, 9, 2519-2535.
26. KLOTZ, K.-N., HESSLING, J., HEGLER, J., OWMAN, C., KULL, B., FREDHOLM, B.B. & LOHSE, M.J. (1998). Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 357, 1-9.
27. 3 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 103-108.
28. q in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol., 56, 705-713.
29. LU, J., PIERRON, A. & RAVID, K. (2003). An adenosine analogue, IB-MECA, down-regulates estrogen receptor α and supresses human breast cancer cell proliferation. Cancer Res., 63, 6413-6423.
30. 3 adenosine receptor activatoin in melanoma cells. Association between receptor fate and tumor growth inhibition. J. Biol Chem., 278, 42121-42130.
31. 3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin. Canc. Res., 10, 4472-4479.
32. MERIGHI, S., MIRANDOLA, P., VARANI, K., GESSI, S., LEUNG, E., BARALDI, P.O., TABRIZI, M.A. & BOREA, P.A. (2003). A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol. Ther., 100, 31-48.
33. 2b adenosine receptors. Br. J. Pharmacol., 122, 1075-1082.
34. 2A adenosine receptor antagonists - future drugs for Parkinson's disease? Drugs Future, 25, 1043-1052.
35. 2A receptors. Trends Pharmacol. Sci., 17, 364-372.
36. PANJEHPOUR, M. & KARAMI-TEHRANI, F. (2004). An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breat cancer cell lines. Int. J. Biochem. Cell Biol., 36, 1502-1509.
37. PIERCE, K.D., FURLONG, T.J., SELBIE, L.-A. & SHINE, J. (1992). Molecular cloning and expression of an adenosine A2b receptor from human brain. Biochem. Biophys. Res. Commun., 187, 86-93.
38. 2 receptor. J. Biol. Chem., 274, 14773-14778.
39. SPICUZZA, L., BONFIGLIO, C. & POLOSA, R. (2003). Research applications and implications of adenosine in diseased airways. Trends Pharmacol. Sci., 24, 409-413.
40. SPYCHALA, J. (2000). Tumor-promoting functions of adenosine. Pharmacol. Ther., 87, 161-173.
41. SPYCHALA, J., LAZAROWSKI, E., OSTAPKOWIECZ, A., AYSCUE, L.H., JIN, A. & MITCHELL, B.S. (2004). Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer. Clin. Canc. Res., 10, 708-717.
42. 2B adensoine receptors in the U87MG tumor cells. Drug Dev. Res., 58, 405-411.